At the Seaver Autism Center for Research and Treatment, our clinical researchers have cultivated unparalleled expertise in the medical and behavioral treatment of children, adolescents, and adults on the autism spectrum. We also study and treat disorders frequently found in autism, including intellectual disability, attention deficits, anxiety, sensory issues, and compulsive behaviors. Our cornerstone is an innovative experimental therapeutics approach, seamlessly investigating psychosocial and psychopharmacological or gene-targeted treatments. This comprehensive strategy allows us to explore both established and novel interventions, continually pushing the boundaries of autism care. Our clinicians employ gold-standard, cutting-edge assessments, ensuring that our research participants and patients receive the most accurate diagnoses and tailored treatment plans available today.

Our research greatly enhances direct patient care at the Center. Our clinicians and clinician-researchers collaborate with various programs and individual investigators to generate new ideas and create opportunities for outstanding clinical and basic science research. Our diverse research portfolio encompasses a wide range of critical areas, including genetics, clinical trials, electrophysiology, biomarker discovery, development of clinical outcome assessments, and natural history studies in rare diseases associated with autism and related conditions. This approach not only enhances our understanding of autism spectrum disorders but also paves the way for groundbreaking treatments and interventions. Through these studies, participants not only contribute to groundbreaking scientific advancements but also receive comprehensive evaluations from our multidisciplinary team at no cost.

A key component of our research is our Biomarker Discovery Program, which utilizes electrophysiological, eye-tracking, and imaging technology to understand underlying pathology and develop objective measures for clinical trials. This program is particularly valuable for our more profoundly affected participants, as it reduces reliance on subjective clinician and caregiver ratings, allowing for more precise measurement of treatment outcomes. These technological advances, combined with our comprehensive clinical assessments, enable us to better understand autism spectrum disorders and develop more effective, targeted interventions.